Page last updated: 2024-11-05

tranexamic acid and Vitreous Hemorrhage

tranexamic acid has been researched along with Vitreous Hemorrhage in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Vitreous Hemorrhage: Hemorrhage into the VITREOUS BODY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, GC1
Chen, LJ1
Liu, HC1
Chen, YJ1
Ramezani, AR1
Ahmadieh, H1
Ghaseminejad, AK1
Yazdani, S1
Golestan, B1

Trials

1 trial available for tranexamic acid and Vitreous Hemorrhage

ArticleYear
Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage; a randomised clinical trial.
    The British journal of ophthalmology, 2005, Volume: 89, Issue:8

    Topics: Adult; Aged; Antifibrinolytic Agents; Confounding Factors, Epidemiologic; Diabetic Retinopathy; Drug

2005

Other Studies

1 other study available for tranexamic acid and Vitreous Hemorrhage

ArticleYear
Development of vitreous haemorrhage during treatment with bevacizumab for metastatic rectal cancer.
    Clinical drug investigation, 2008, Volume: 28, Issue:8

    Topics: Adenocarcinoma; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Human

2008